SUSMED Co., Ltd. announced a private placement for gross proceeds of ¥720,000,000 on June 4, 2018. The transaction included participation from new investors Tokyo Century Corporation (TSE:8439), M3, Inc. (TSE:2413), SBI Investment Co., Ltd., Sony Innovation Fund, The Dai-Ichi Life Insurance Company, Limited, and existing investor Beyond Next Ventures Inc. The company issued shares through a third party allocation method.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
532 JPY | +0.19% | -3.80% | -60.15% |
2023 | SUSMED,Inc.(TSE:4263) added to S&P Global BMI Index | CI |
2022 | Walgreens Boots Alliance, Inc. Joins Sustainable Medicines Partnership | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,530 JPY | -3.62% | -5.21% | 6.85B | ||
1,461 JPY | +1.14% | -3.66% | 4.7B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.15% | 58.25M | |
-12.82% | 193B | |
+2.64% | 167B | |
+4.35% | 160B | |
+7.95% | 104B | |
+34.09% | 83.55B | |
+12.22% | 82.75B | |
-4.57% | 72.35B | |
-22.32% | 54.73B | |
-7.68% | 43.68B |
- Stock Market
- Equities
- 4263 Stock
- News SUSMED,Inc.
- SUSMED Co., Ltd. announced that it has received ¥720 million in funding from Tokyo Century Corporation, M3, Inc., SBI Investment Co., Ltd., Beyond Next Ventures Inc., Sony Innovation Fund, The Dai-Ichi Life Insurance Company, Limited